A Oryan
Overview
Explore the profile of A Oryan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
627
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khanbazi M, Bigham-Sadegh A, Oryan A, Meimandi-Parizi A, Jannesar A
Injury
. 2024 Feb;
55(3):111396.
PMID: 38341998
Background: Critical size defects are one of the challenges in the treatment of fractures in humans and animals. Blood products such as leukocyte-SAand platelet-rich fibrin (L-PRF) are one of the...
2.
Oryan A, Hassanajili S, Sahvieh S
Iran J Vet Res
. 2023 Oct;
24(2):122-125.
PMID: 37790115
Background: One of the most common concerns in the regeneration of massive bone defects necessitating surgery and bone grafts is the application of tissue engineering using drug delivery. Zoledronate is...
3.
Bahrami S, Oryan A, Bemani E
J Infect Chemother
. 2021 Feb;
27(7):984-990.
PMID: 33637428
Introduction: The aim of the present study was to evaluate in vitro and in vivo efficacy of combination therapy of amiodarone and voriconazole against Leishmania major and investigating immune and...
4.
Oryan A, Hassanajili S, Sahvieh S, Azarpira N
Life Sci
. 2020 Jul;
257:118038.
PMID: 32622947
Purpose: The importance of regeneration in large bone defects forces the orthopedic surgeons to search for a proper methodology. The present experiment evaluated the capability of polylactic acid/polycaprolactone/hydroxyapatite (PLA/PCL/HA) scaffold...
5.
Bemani E, Oryan A, Bahrami S
Exp Parasitol
. 2019 Aug;
205:107747.
PMID: 31442454
Development of new chemotherapeutic agents is an essential issue in the treatment and control of a disease. This study aimed to evaluate the anti-leishmanial activity of amiodarone, an antiarrhythmic class...
6.
Meimandi-Parizi A, Oryan A, Bigham-Sadegh A, Sayahi E
Iran J Vet Res
. 2019 Feb;
19(4):246-254.
PMID: 30774664
The aim of this study was to compare the efficacy of honey bee venom (BV) and royal jelly (RJ) alongside chitosan scaffold (CS) in improving radius bone defect in rats....
7.
Oryan A, Bemani E, Bahrami S
Acta Trop
. 2018 Apr;
185:34-41.
PMID: 29689189
Leishmaniasis is a group of human and animal diseases causing 20,000-40,000 annual deaths and its etiological agents belong to the Leishmania genus. The most current treatment against leishmaniasis is chemotherapy....
8.
Oryan A, Alemzadeh E, Moshiri A
J Wound Care
. 2017 Jan;
26(1):5-19.
PMID: 28103165
Burns are the most extensive forms of soft tissue injuries occasionally resulting in extensive and deep wounds and death. Burns can lead to severe mental and emotional distress, because of...
9.
Oryan A, Akbari M
Asian Pac J Trop Med
. 2016 Oct;
9(10):925-932.
PMID: 27794384
Recently, vector-borne parasitic diseases such as leishmaniasis have been emerged or re-emerged in many geographical areas and resulted in global health and economic concerns that involve humans, domestic animals and...
10.
Oryan A, Sadoughifar R, Namavari M
J Parasit Dis
. 2016 Sep;
40(3):699-706.
PMID: 27605770
It has been shown that mice, particularly the BALB/c ones, are susceptible to infection by some of the apicomplexan parasites. To compare the susceptibility of the inbred BALB/c, outbred BALB/c...